| ACS | Acute coronary syndrome |
| ADP | Adenosine diphosphate |
| AEs | Adverse events |
| AF | Atrial fibrillation |
| ATP | Adenosine triphosphate |
| C3 | Complement 3 |
| CAPs | Carboxy(alkylpyrrole) protein adducts |
| CD62P | P-selectin |
| cGMP | Cyclic guanosine monophosphate |
| CVD | Cardiovascular disease |
| DAMP | Damage-associated molecular pattern |
| DAPT | Dual anti-platelet therapy |
| FSL-1 | Fibroblast stimulating lipopeptide-1 |
| GP | Glycoprotein |
| HCMV | Human cytomegalovirus |
| HMGB1 | High Mobility Group Box 1 |
| IL | Interleukin |
| LPS | Lipopolysaccharide |
| MALP-2 | Macrophage Activating Lipopeptide-2 |
| MIP | Macrophage inflammatory protein |
| MPO | Myeloperoxidase |
| MPs | Microparticles |
| mtDNA | Mitochondrial DNA |
| NET | Neutrophil extracellular trap |
| NF-κB | Nuclear factor-kappa B |
| oxPC | Oxidized phospholipids |
| PAMP | Pathogen-associated molecular pattern |
| PBMCs | Peripheral blood mononuclear cells |
| PC | Platelet components |
| PF4 | Platelet factor 4 |
| PGSL-1 | P-selectin glycoprotein ligand-1 |
| PRP | Platelet-rich plasma |
| PRR | Pattern recognition receptor |
| RAGE | Receptor for advanced glycation end products |
| RANTES | Regulated upon Activation, Normal T cell Expressed and Secreted |
| sCD40L | Soluble CD40L |
| TGF-β | Transforming growth factor-β |
| TLRs | Toll-like receptors |
| TNF-α | Tumor necrosis factor-alpha |
| TRAP | Thrombin receptor activator peptide |
| Treg | Regulatory T cells |
| TxA2 | Thromboxane A2 |
| VAMP | Vesicle-associated membrane protein |
| vWF | Von Willebrand factor |
| WPs | Washed platelets |